05:44 PM EDT, 05/13/2024 (MT Newswires) -- Andrew Reardon, Chief Legal Officer, on May 09, 2024, sold 10,000 shares in Ligand Pharmaceuticals ( LGND ) for $830,449. Following the Form 4 filing with the SEC, Reardon has control over a total of 22,205 shares of the company, with 22,205 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/886163/000200101124000051/xslF345X03/edgardoc.xml

Price: 84.21, Change: +0.14, Percent Change: +0.17